The aforementioned effects of ANXA5 were demonstrated in a rabbit experimental model, in which diannexin, a dimer of ANXA5, was used as a treatment after myocardial ischemia and reperfusion with cardioprotective abilities by reducing no-reflow areas (Hale et al., 2011). This evidence concerns the gene ANXA5 and myocardial ischemia.